SEC Form 4 · accession 0001209191-16-150868
Myovant Sciences Ltd. · MYOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrie Curran
Director
Period of report
Nov 15, 2016
Accepted (ET)
Nov 17, 2016 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001679082
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $11.30 | Nov 15, 2016 | A | 33,846 | A | — | Nov 14, 2026 | Common Shares | 33,846 | 33,846 | D |
Explanation of responses
- F11/3 of the shares underlying the option shall vest and become exercisable on November 15, 2017; the balance of the shares shall vest and become exercisable in a series of eight (8) successive equal quarterly installments measured from November 15, 2017, subject to the Reporting Person providing continuous service to the Issuer on each such date.